Related Experiment Video
Updated: Aug 7, 2026

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
Published on: October 21, 2017
Influence of C57BL/6 Sub-Strain on the Innate Immune Response and Liver Recovery Following Acetaminophen-Induced
Giselle Sanchez-Guerrero1, Diego K Chavez1, Hartmut Jaeschke1
1Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA.
Abstract:
Acetaminophen (APAP) overdose is a leading cause of acute liver failure, and the inadequacy of the current antidote N-acetylcysteine motivates the search for newer therapeutic interventions. This is facilitated by the replication of human pathophysiology by the mouse model, with the C57BL/6 strain being most used. While variations in susceptibility to liver injury between the C57BL/6(J) and (N) substrains are well recognized, substrain influence on the innate immune response and regenerative outcomes which influence development of acute liver failure are unknown. We compared these aspects temporally between 6J and 6N mice following a 300 mg/kg APAP overdose. Consistent with prior findings, 6N mice exhibited higher liver injury compared to 6J mice. Neutrophil and macrophage infiltration followed similar patterns, but with different temporal dynamics, with 6J mice showing a rapid but transient response, while 6N mice exhibited delayed and prolonged immune activity. Importantly, these immune dynamics were accompanied by delayed regeneration and sustained p21 expression, indicating impaired regeneration in 6N mice. Taken together, both substrains displayed broadly similar immune behavior in terms of cytokine expression and cell recruitment patterns, with the delayed immune resolution and regeneration observed in 6N mice being reflective of the extent of injury rather than intrinsic differences in immune function. Thus, our study emphasizes the need to evaluate multiple time points to fully capture the evolving nature of liver injury and recovery during APAP hepatotoxicity. It also underscores the importance of clearly considering and reporting mouse substrain and vendor, as these factors can significantly shape experimental outcomes and may explain discrepancies between studies using this clinically relevant model.
Insights
Mouse substrain differences impact acetaminophen overdose outcomes. C57BL/6N mice show greater liver injury and delayed regeneration compared to C57BL/6J mice, highlighting the need for careful consideration of mouse models in liver injury research.
Area of Science:
- Hepatology and Toxicology
- Immunology and Innate Immunity
- Regenerative Medicine
Background:
- Acetaminophen (APAP) overdose is a primary cause of acute liver failure.
- N-acetylcysteine is the current antidote, but its limitations necessitate new therapeutic strategies.
- Mouse models, particularly C57BL/6 substrains, are crucial for studying APAP hepatotoxicity.
Purpose of the Study:
- To compare the temporal innate immune response and regenerative outcomes between C57BL/6J (6J) and C57BL/6N (6N) mice after APAP overdose.
- To investigate how substrain-specific differences influence the development of acute liver failure.
Main Methods:
- Administered a 300 mg/kg APAP overdose to both 6J and 6N mice.
- Analyzed liver injury, neutrophil and macrophage infiltration, cytokine expression, and p21 expression at multiple time points.
- Assessed temporal dynamics of immune cell recruitment and liver regeneration.
Main Results:
- 6N mice exhibited significantly higher liver injury compared to 6J mice.
- Immune cell infiltration patterns differed temporally: 6J mice showed rapid, transient responses, while 6N mice displayed delayed, prolonged immune activity.
- Delayed regeneration and sustained p21 expression were observed in 6N mice, indicating impaired liver repair.
Conclusions:
- Substrain differences in C57BL/6 mice influence the temporal dynamics of immune response and regeneration following APAP overdose.
- Delayed immune resolution and impaired regeneration in 6N mice correlate with the extent of liver injury, not intrinsic immune function differences.
- Emphasizes the critical need to report mouse substrain and vendor, and to evaluate multiple time points in APAP hepatotoxicity studies.

